HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Response of chronic neuropathic pain syndromes to ketamine: a preliminary study.

Abstract
Hyperactivity of N-methyl-D-aspartate (NMDA) receptors may be one of the factors in the genesis of neuropathic pain. Ketamine is an NMDA-blocking agent widely used in human medicine. Ketamine (at 250 mcg/kg i.v. slow push) was administered to 6 patients for control of chronic neuropathic pain syndromes in double-blind placebo-controlled fashion. All 3 patients with peripheral nervous system (PNS) disease-related pain, and 2 of 3 patients with central pain and dysesthesia syndromes responded with a temporary decrease in the rating of ongoing pain. The allodynia, hyperalgesia and after-sensation present in 5 patients improved after the administration of ketamine. Dose-response estimation in 2 patients with PNS-related neuropathic pain revealed that ketamine was effective in dose-related fashion. Continuous subcutaneous infusion of ketamine administered to 1 patient with PNS-related neuropathic pain caused no additional improvement in pain control but caused intolerable cognitive and memory side effects. In contrast, side effects during single-dose injections were mild and well tolerated. Ketamine affected the evoked pain and associated after-sensation in chronic neuropathic pain syndromes more than the ongoing constant pain.
AuthorsMiroslav Backonja, George Arndt, Kathy A Gombar, Bill Check, Mary Zimmermann
JournalPain (Pain) Vol. 56 Issue 1 Pg. 51-57 (Jan 1994) ISSN: 0304-3959 [Print] United States
PMID8159441 (Publication Type: Case Reports, Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Receptors, N-Methyl-D-Aspartate
  • Ketamine
Topics
  • Adult
  • Aged
  • Chronic Disease
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Female
  • Humans
  • Hyperalgesia (drug therapy)
  • Injections, Subcutaneous
  • Ketamine (administration & dosage, adverse effects, therapeutic use)
  • Male
  • Middle Aged
  • Pain (drug therapy, physiopathology)
  • Receptors, N-Methyl-D-Aspartate (drug effects)
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: